TY - JOUR
T1 - Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia
AU - Gautam, Samir
AU - Cohen, Avi J.
AU - Stahl, Yannick
AU - Valda Toro, Patricia
AU - Young, Grant M.
AU - Datta, Rupak
AU - Yan, Xiting
AU - Ristic, Nicholas T.
AU - Bermejo, Santos D.
AU - Sharma, Lokesh
AU - Restrepo, Marcos I.
AU - Dela Cruz, Charles S.
N1 - Publisher Copyright:
©
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Introduction Procalcitonin expression is thought to be stimulated by bacteria and suppressed by viruses via interferon signalling. Consequently, during respiratory viral illness, clinicians often interpret elevated procalcitonin as evidence of bacterial coinfection, prompting antibiotic administration. We sought to evaluate the validity of this practice and the underlying assumption that viral infection inhibits procalcitonin synthesis. Methods We conducted a retrospective cohort study of patients hospitalised with pure viral infection (n=2075) versus bacterial coinfection (n=179). The ability of procalcitonin to distinguish these groups was assessed. In addition, procalcitonin and interferon gene expression were evaluated in murine and cellular models of influenza infection. Results Patients with bacterial coinfection had higher procalcitonin than those with pure viral infection, but also more severe disease and higher mortality (p<0.001). After matching for severity, the specificity of procalcitonin for bacterial coinfection dropped substantially, from 72% to 61%. In fact, receiver operating characteristic curve analysis showed that procalcitonin was a better indicator of multiple indices of severity (eg, organ failures and mortality) than of coinfection. Accordingly, patients with severe viral infection had elevated procalcitonin. In murine and cellular models of influenza infection, procalcitonin was also elevated despite bacteriologic sterility and correlated with markers of severity. Interferon signalling did not abrogate procalcitonin synthesis. Discussion These studies reveal that procalcitonin rises during pure viral infection in proportion to disease severity and is not suppressed by interferon signalling, in contrast to prior models of procalcitonin regulation. Applied clinically, our data suggest that procalcitonin represents a better indicator of disease severity than bacterial coinfection during viral respiratory infection.
AB - Introduction Procalcitonin expression is thought to be stimulated by bacteria and suppressed by viruses via interferon signalling. Consequently, during respiratory viral illness, clinicians often interpret elevated procalcitonin as evidence of bacterial coinfection, prompting antibiotic administration. We sought to evaluate the validity of this practice and the underlying assumption that viral infection inhibits procalcitonin synthesis. Methods We conducted a retrospective cohort study of patients hospitalised with pure viral infection (n=2075) versus bacterial coinfection (n=179). The ability of procalcitonin to distinguish these groups was assessed. In addition, procalcitonin and interferon gene expression were evaluated in murine and cellular models of influenza infection. Results Patients with bacterial coinfection had higher procalcitonin than those with pure viral infection, but also more severe disease and higher mortality (p<0.001). After matching for severity, the specificity of procalcitonin for bacterial coinfection dropped substantially, from 72% to 61%. In fact, receiver operating characteristic curve analysis showed that procalcitonin was a better indicator of multiple indices of severity (eg, organ failures and mortality) than of coinfection. Accordingly, patients with severe viral infection had elevated procalcitonin. In murine and cellular models of influenza infection, procalcitonin was also elevated despite bacteriologic sterility and correlated with markers of severity. Interferon signalling did not abrogate procalcitonin synthesis. Discussion These studies reveal that procalcitonin rises during pure viral infection in proportion to disease severity and is not suppressed by interferon signalling, in contrast to prior models of procalcitonin regulation. Applied clinically, our data suggest that procalcitonin represents a better indicator of disease severity than bacterial coinfection during viral respiratory infection.
KW - Bacterial Infection
KW - Pneumonia
KW - Respiratory Infection
KW - Viral infection
UR - http://www.scopus.com/inward/record.url?scp=85090123429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090123429&partnerID=8YFLogxK
U2 - 10.1136/thoraxjnl-2020-214896
DO - 10.1136/thoraxjnl-2020-214896
M3 - Article
C2 - 32826284
AN - SCOPUS:85090123429
SN - 0040-6376
VL - 75
SP - 974
EP - 981
JO - Thorax
JF - Thorax
IS - 11
ER -